Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Safety and Immunogenicity of an Anti–Zika Virus DNA Vaccine

2017; Massachusetts Medical Society; Volume: 385; Issue: 12 Linguagem: Inglês

10.1056/nejmoa1708120

ISSN

1533-4406

Autores

Pablo Tebas, Christine C. Roberts, Kar Muthumani, Emma L. Reuschel, Sagar B. Kudchodkar, Faraz I. Zaidi, S. M. White, Amir Sada Khan, Trina Racine, Hyeree Choi, Jean Boyer, Young K. Park, Sylvie Trottier, Celine Remigio, Diane Krieger, Susan E. Spruill, Mark L. Bagarazzi, Gary Kobinger, David B. Weiner, Joel N. Maslow,

Tópico(s)

Viral Infections and Vectors

Resumo

Although Zika virus (ZIKV) infection is typically self-limiting, other associated complications such as congenital birth defects and the Guillain-Barré syndrome are well described. There are no approved vaccines against ZIKV infection.

Referência(s)